PROFKA, ERISELDA
PROFKA, ERISELDA
Dipartimento di Scienze Cliniche e di Comunità
A case of testicular atrophy associated with cystic fibrosis
2020 E. Profka, G. Rodari, F. Giacchetti, A. Berrettini, G. Manzoni, V. Dacco, M. Arosio, C. Giavoli, C. Colombo
A single-centre study on predictors and determinants of pubertal delay and growth impairment in Epidermolysis Bullosa
2022 G. Rodari, S. Guez, S. Salera, F.M. Ulivieri, G. Tadini, M. Brena, E. Profka, F. Giacchetti, M. Arosio, C. Giavoli
Adrenal insufficiency at the time of COVID-19: a retrospective study in patients referring to a tertiary centre
2021 G. Carosi, V. Morelli, G. Del Sindaco, A.L. Serban, A. Cremaschi, S. Frigerio, G. Rodari, E. Profka, R. Indirli, R. Mungari, V. Resi, E. Orsi, E. Ferrante, A. Dolci, C. Giavoli, M. Arosio, G. Mantovani
Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma
2015 E. Profka, C. Giavoli, S. Bergamaschi, E. Ferrante, E. Malchiodi, E. Sala, E. Verrua, G. Rodari, M. Filopanti, P. Beck-Peccoz, A. Spada
Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa
2017 G. Rodari, S. Guez, F.M.P. Manzoni, K.K. Chalouhi, E. Profka, S. Bergamaschi, S. Salera, G. Tadini, F.M. Ulivieri, A. Spada, C. Giavoli, S. Esposito
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency
2013 E. Ferrante, A.E. Malavazos, C. Giavoli, F. Ermetici, C. Coman, S. Bergamaschi, E. Profka, S. Briganti, C.L. Ronchi, E. Passeri, S. Corbetta, A.G. Lania, A. Spada, G. Iacobellis, B. Ambrosi, P. Beck Peccoz
Evaluation of pituitary function after infectious meningitis in childhood
2014 C. Giavoli, C. Tagliabue, E. Profka, L. Senatore, S. Bergamaschi, G. Rodari, A. Spada, P. Beck-Peccoz, S. Esposito
Focus on GH deficiency and thyroid function
2017 C. Giavoli, E. Profka, G. Rodari, A. Lania, P. Beck-Peccoz
GH Deficiency and Replacement Therapy in Hypopituitarism: Insight Into the Relationships With Other Hypothalamic-Pituitary Axes
2021 E. Profka, G. Rodari, F. Giacchetti, C. Giavoli
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency
2012 C. Giavoli, E. Profka, E. Verrua, C. Ronchi, E. Ferrante, S. Bergamaschi, E. Sala, E. Malchiodi, A.G. Lania, M. Arosio, B. Ambrosi, A. Spada, P. Beck-Peccoz
Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues.
2020 C. Giavoli, E. Profka, N. Giancola, G. Rodari, F. Giacchetti, E. Ferrante, M. Arosio, G. Mantovani
Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas : focus on the Prevalence of Isolated Central Hypoadrenalism
2015 G. Carosi, E. Malchiodi, E. Ferrante, E. Sala, E. Verrua, E. Profka, C. Giavoli, M. Filopanti, P. Beck-Peccoz, A. Spada, G. Mantovani
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
2014 C. Giavoli, E. Profka, E. Sala, M. Filopanti, A.M. Barbieri, S. Bergamaschi, E. Ferrante, M. Arosio, B. Ambrosi, A.G. Lania, A. Spada, P. Beck-Peccoz
Influence of biochemical diagnosis of growth hormone deficiency on replacement therapy response and retesting results at adult height
2021 G. Rodari, E. Profka, F. Giacchetti, I. Cavenaghi, M. Arosio, C. Giavoli
Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders?
2012 E. Ferrante, V. Morelli, C. Giavoli, G. Mantovani, E. Verrua, E. Sala, E. Malcmiodi, S. Bergamaschi, E. Profka, E. Cairoli, S. Palmieri, I. Chiodini, A.G. Lania, A. Spada, P. Beck-Peccoz
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
2017 D. Ferone, E. Profka, V. Gasco, M.R. Ambrosio, A. Colao, C. Di Somma, E. Puxeddu, G. Arnaldi, C. Pagano, E. Zecchi, A. Pietropoli, P. Beck-Peccoz
Procoagulant imbalance in Klinefelter syndrome assessed by thrombin generation assay and whole blood thromboelastometry
2021 R. Indirli, E. Ferrante, E. Scalambrino, E. Profka, M. Clerici, T. Lettera, A.L. Serban, W. Vena, A. Pizzocaro, M. Bonomi, B. Cangiano, G. Carosi, G. Mazziotti, L. Persani, A. Lania, M. Arosio, F. Peyvandi, G. Mantovani, A. Tripodi
Progressive bone impairment with age and pubertal development in neurofibromatosis type I
2018 G. Rodari, G. Scuvera, F.M. Ulivieri, E. Profka, F. Menni, V. Saletti, S. Esposito, S. Bergamaschi, E. Ferrante, C. Eller-Vainicher, S. Esposito, M. Arosio, C. Giavoli
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas
2016 E. Sala, P. Bellaviti Buttoni, E. Malchiodi, E. Verrua, G. Carosi, E. Profka, G. Rodari, M. Filopanti, E. Ferrante, A. Spada, G. Mantovani
Short stature in PRMT7 Mutations: first evidence of response to growth hormone treatment
2022 G. Rodari, R. Villa, M. Porro, S. Gangi, M. Iascone, F. Elli, F. Giacchetti, E. Profka, V. Collini, A. Dall'Antonia, M. Arosio, G. Mantovani, M.F. Bedeschi, C. Giavoli